The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure*
Abstract
The bioavailability, pharmacokinetics, and pharmacodynamics of torsemide (10 mg orally and intravenously) and furosemide (40 mg orally and 20 mg intravenously) were determined in a randomized crossover clinical trial in 16 patients with compensated congestive heart failure. Torsemide (time to reach maximum concentration [tmax], 1.1 +/- 0.9 hour) was more rapidly absorbed than furosemide (tmax, 2.4 +/- 2.5 hours), the absorption of which was delayed compared with that in healthy volunteers. Bioavailability of torsemide was also greater and less variable than that of furosemide. All four treatments yielded comparable changes from baseline in 24-hour electrolyte excretion. Based on the relationships between sodium excretion rate and fractional sodium and urinary drug excretion rate, response to both diuretic agents at the level of the nephron was decreased compared with previous studies with healthy subjects. Assessment of the clinical relevance, if any, of the difference in the variability of absorption warrants further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Swedberg, K., Eneroth, P., Kjekshus, J., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,153
Furosemide Absorption Altered in Decompensated Congestive Heart Failure
VASKO, M. R., BROWN-CARTWRIGHT, D., KNOCHEL, J. P., NIXON, J. V., & BRATER, D. C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-3-314 · Cited by 219
Self-citationBumetanide and furosemide in heart failure
Brater, D. C., Day, B., Burdette, A., & Anderson, S. (1984) · Kidney International · doi:10.1038/ki.1984.153 · Cited by 174
Self-citationHammarlund, M., Paalzow, L., & Odlind, B. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00630286 · Cited by 132
Furosemide in patients with heart failure: Shift in dose-response curves
Brater, D. C., Chennavasin, P., & Seiwell, R. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.148 · Cited by 127
Self-citationAldosterone and antialdosterone therapy in congestive heart failure
Weber, K. T., & Villarreal, D. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90238-8 · Cited by 107
Patterson, J. H., Adams, K. F., Applefeld, M. M., Corder, C. N., Mâsse, B. R., & The Torsemide Investigators Group (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02848.x · Cited by 88
Wittner, M., Stefano, A. D., Wangemann, P., et al. (1991) · Drugs · doi:10.2165/00003495-199100413-00003 · Cited by 77
Patterson, J. H., Adams, K. F., Applefeld, M. M., Corder, C. N., & Mâsse, B. R. (1994) · PubMed · Cited by 67
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Metadata
- Authors
- Vargo, D. L., Kramer, W. G., Black, P. K., Smith, W. B., Serpas, T., & Brater, D. C.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1995-06
- Volume
- 57
- Issue
- 6
- Pages
- 601-609
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W1992857605
- Cited by
- 298
- References
- 11
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure*. https://app.cochat.ai/papers/10.1016/0009-9236(95)90222-8
- The paper
- Vargo, D. L., Kramer, W. G., Black, P. K., Smith, W. B., Serpas, T., & Brater, D. C. (1995). Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure*. Clinical Pharmacology & Therapeutics. https://doi.org/10.1016/0009-9236(95)90222-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.